Discover how we manage routine and specialty test for a Phase 1 study.
Phase 1 Dose Escalation in RRMM Using Bispecific Antibody
Created: January 15, 2025
Case Study – Refractory Multiple Myeloma (RRMM)
Reach out to our experts and discover how we can help you advance your clinical trial
